Improving safe use of blood thinners through better collaboration between doctors and pharmacists
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use
This study is looking at ways to make sure that the blood-thinning medications you take are safe by improving the alerts that doctors and pharmacists use when prescribing them, so you can get the best care possible.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10705628 on NIH RePORTER |
What this research studies
This research focuses on enhancing the safety of direct oral anticoagulant medications, which are used to prevent blood clots in conditions like pulmonary embolism and atrial fibrillation. It aims to improve existing electronic health record (EHR) alert systems that notify healthcare providers about unsafe prescriptions based on patient-specific factors. By fostering collaboration between prescribing doctors and pharmacists, the study will evaluate different alert types to determine which most effectively promotes safe prescribing practices. Patients will benefit from improved monitoring and tailored medication management, ensuring they receive the safest and most effective treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who are prescribed direct oral anticoagulants for conditions like atrial fibrillation or those at risk for thrombotic events.
Not a fit: Patients who are not prescribed anticoagulant medications or those with contraindications to their use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the risk of unsafe anticoagulant prescriptions, leading to better patient outcomes and fewer complications.
How similar studies have performed: Previous research has shown that collaborative care models and improved alert systems can enhance medication safety, indicating a promising approach in this study.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Barnes, Geoffrey Douglas — University of Michigan at Ann Arbor
- Study coordinator: Barnes, Geoffrey Douglas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.